BIO-TECHNE Corp 4
4 · BIO-TECHNE Corp · Filed Jul 12, 2016
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Gould Kevin S
SVP Clinical Controls
Transactions
- Tax Payment
Common Stock
2016-07-09$115.17/sh−309$35,588→ 2,191 total
Holdings
- 50,000
Stock Options (Right to buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying) - 15,000
Stock Options (Right to buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying) - 10,000
Stock Options (Right to buy)
Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]1. The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit gran by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
- [F2]2. Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- [F3]4. 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
- [F4]3. Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19.
- [F5]5. Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.